ADVANCED ENZYME TECHNOLOGIES
|
The Current P/B Ratio of ADVANCED ENZYME TECHNOLOGIES is 3.01.
Share Price | ₹355.5 | Dec 24,2024 |
Market Cap | ₹3,977.5 Cr | |
Book Value | ₹1,321.1 Cr | Mar2024 - Consolidated Results |
Price/Book | 3.01x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of ADVANCED ENZYME TECHNOLOGIES
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹3,977.5 Cr] as on Dec 24,2024
(/) Book Value [ ₹1,321.1 Cr] based on Mar2024 - Consolidated Results
(=) P/B Ratio [ 3.01x ]
Thus, for ADVANCED ENZYME TECHNOLOGIES , the investors are currently willing to pay '3.01 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of ADVANCED ENZYME TECHNOLOGIES !
The chart below summarizes the trend in P/B Ratio of ADVANCED ENZYME TECHNOLOGIES over the last five years.
Historical PB (Price/Book ) ratio chart of ADVANCED ENZYME TECHNOLOGIES
PB Ratio Performance Analysis for ADVANCED ENZYME TECHNOLOGIES
- ADVANCED ENZYME TECHNOLOGIES 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 2.77x.
- ADVANCED ENZYME TECHNOLOGIES 's operated at median p/b ratio of 2.9x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ADVANCED ENZYME TECHNOLOGIES 's p/b ratio peaked in Mar2021 at 3.98x.
- ADVANCED ENZYME TECHNOLOGIES 's p/b ratio hit its five-year low in Mar2020 of 1.91x.
How does ADVANCED ENZYME TECHNOLOGIES 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
ADVANCED ENZYME TECHNOLOGIES | 1,321.10 | 3.01 | 3,977.5 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 63,666.80 | 6.85 | 436,103.0 |
CIPLA LTD | 26,619.90 | 4.52 | 120,270.0 |
DR REDDYS LABORATORIES LTD | 28,123.50 | 4.01 | 112,752.0 |
ZYDUS LIFESCIENCES LTD | 19,829.50 | 4.89 | 97,041.2 |
DIVIS LABORATORIES LTD | 13,571.00 | 11.31 | 153,540.0 |
MANKIND PHARMA LTD | 9,339.84 | 12.86 | 120,073.0 |
TORRENT PHARMACEUTICALS LTD | 6,856.15 | 16.79 | 115,112.0 |
LUPIN LTD | 14,175.80 | 6.98 | 98,925.3 |
AUROBINDO PHARMA LTD | 29,842.80 | 2.44 | 72,945.8 |
ABBOTT INDIA LTD | 3,658.73 | 16.63 | 60,844.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs ADVANCED ENZYME TECHNOLOGIES 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 2.44x |
Max industry PB | 16.79x |
Median industry PB | 6.85x |
Average industry PB | 8.21x |
You may also like the below Video Courses